Pharmaceuticals giant Bristol-Myers Squibb has announced that its offer to exchange its shares for stock in Mead Johnson – part of its plan to spin-off the baby food maker – has been oversubscribed.


In a regulatory announcement, BMS said that 269.3m shares would be accepted, but 500.5m were tendered.


Shareholders who tendered at least 100 shares will get 53.8% of their BMS shares swapped for Mead Johnson shares.


The exchange ratio was set at 0.6313 Mead Johnson shares for each BMS share.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now